Predictors of chemotherapy and its effects in early stage squamous cell carcinoma of the larynx
Autor: | Richard White, Larisa Greenberg, Rodney E. Wegner, Thejus T. Jayakrishnan, Athanasios Colonias |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
Oncology
medicine.medical_specialty medicine.medical_treatment Head and Neck and Tumor Biology lcsh:Surgery chemotherapy survival supraglottis Internal medicine medicine Prospective cohort study radiotherapy Original Research Chemotherapy Proportional hazards model business.industry Head and neck cancer Cancer General Medicine lcsh:RD1-811 medicine.disease lcsh:Otorhinolaryngology lcsh:RF1-547 subglottis Radiation therapy National Cancer Database Propensity score matching laryngeal cancer glottis Outcomes research business |
Zdroj: | Laryngoscope Investigative Otolaryngology, Vol 5, Iss 3, Pp 445-452 (2020) Laryngoscope Investigative Otolaryngology |
ISSN: | 2378-8038 |
Popis: | Background Squamous cell carcinoma (SCC) of larynx is a common head and neck cancer. For cases that are node negative, the role of definitive concurrent chemoradiation is unclear and not supported by guidelines but used at provider discretion. To address this knowledge gap, we examined the oncological outcomes with additional chemotherapy and factors correlated with the chemotherapy administration. Methods We queried the National Cancer Database for patients with early stage (T2N0M0) laryngeal SCC treated nonsurgically. Multivariable logistic regression identified predictors of chemotherapy. Multivariable Cox regression evaluated predictors of survival. Propensity matching accounted for indication biases. Results We identified 7181 patients meeting the eligibility criteria, of which 1568 (22%) patients received chemotherapy in addition to radiation. Predictors of chemotherapy use included younger age, Caucasian race, more remote year of treatment, higher grade, sites other than glottis, treatment at a community cancer center, and use of intensity‐modulated radiation therapy. Median overall survival was not significantly different in the two arms analyzed—65 months (95% confidence interval [CI] 60, 72months) with chemotherapy compared to 70 months without chemotherapy (95% CI 66, 75 months, P |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |